The original short thesis for MSFT remains intact. The stock is trading just below a critical 4-hour resistance level ($500.05), with overbought conditions confirmed by a declining RSI (78.37) and weakening MACD histogram. The broader sector and rates environment continue to support the short case, and the first adverse barrier has not been breached. The stop at $508.00 remains intact, preserving the asymmetric risk/reward profile.
The original short thesis at $495.61 was based on overextension after a massive post-earnings surge. That overextension is now at an extreme: 4h RSI 78.37, 30-min RSI already falling sharply from 59 to 55, and MACD bearish-crossed on the 30-min. Price is pinned at a low-volume node ($501.37 LVN) far above the value area, with the nearest 4h support at $499.44 already being tested. The mean-reversion setup is actually becoming more compelling, not less, as momentum rolls over from extreme levels. The $508 stop provides 1.7% downside protection while the $472 target offers 5.5% potential — the risk/reward remains favorable.
The mean-reversion short thesis remains intact: MSFT is pinned under 4h/1day resistance ($500.05/$501.55) in a thin low-volume node far above its POC ($389) and value area, with RSI at 78-82 flashing extreme overextension and MACD histograms now falling on both 4h and daily plus a 30m bearish zero-cross. Price is only +0.8% from entry with the $508 stop untouched, so the $472 target path and favorable R/R are still fully open with 12 days left in the horizon.
No model argued for EXIT.
The mean-reversion short thesis remains intact: MSFT is pinned under 4h/1day resistance ($500.05/$501.55) in a thin low-volume node far above its POC ($389) and value area, with RSI at 78-82 flashing extreme overextension and MACD histograms now falling on both 4h and daily plus a 30m bearish zero-cross. Price is only +0.8% from entry with the $508 stop untouched, so the $472 target path and favorable R/R are still fully open with 12 days left in the horizon.
The mean-reversion short thesis remains intact: MSFT is pinned under 4h/1day resistance ($500.05/$501.55) in a thin low-volume node far above its POC ($389) and value area, with RSI at 78-82 flashing extreme overextension and MACD histograms now falling on both 4h and daily plus a 30m bearish zero-cross. Price is only +0.8% from entry with the $508 stop untouched, so the $472 target path and favorable R/R are still fully open with 12 days left in the horizon.
▼ Click to expandThe short could be closed because the confirmed bullish regime (65%), sector confirmation (XLK +6.28%, TLT aligned), and a still-intact primary daily uptrend (price 18-23% above SMA20/50) mean overbought conditions may persist rather than revert, as they did during the post-earnings 15.5% surge; price refusing to roll over at resistance is non-confirmation of the reversal and risks a grind to the $508 stop.
▼ Click to expandThe original short thesis at $495.61 was based on overextension after a massive post-earnings surge. That overextension is now at an extreme: 4h RSI 78.37, 30-min RSI already falling sharply from 59 to 55, and MACD bearish-crossed on the 30-min. Price is pinned at a low-volume node ($501.37 LVN) far above the value area, with the nearest 4h support at $499.44 already being tested. The mean-reversion setup is actually becoming more compelling, not less, as momentum rolls over from extreme levels. The $508 stop provides 1.7% downside protection while the $472 target offers 5.5% potential — the risk/reward remains favorable.
The original short thesis at $495.61 was based on overextension after a massive post-earnings surge. That overextension is now at an extreme: 4h RSI 78.37, 30-min RSI already falling sharply from 59 to 55, and MACD bearish-crossed on the 30-min. Price is pinned at a low-volume node ($501.37 LVN) far above the value area, with the nearest 4h support at $499.44 already being tested. The mean-reversion setup is actually becoming more compelling, not less, as momentum rolls over from extreme levels. The $508 stop provides 1.7% downside protection while the $472 target offers 5.5% potential — the risk/reward remains favorable.
▼ Click to expandThe stock has continued to grind higher since entry (+0.8%), and the bullish regime is confirmed with broad equity participation and small-cap leadership. The post-earnings momentum is strong with Azure accelerating to 43% growth and $678B in remaining performance obligations. Price has not yet shown a clean rejection at resistance, and the 4h RSI at 78 is still in overbought territory without a confirmed bearish crossover on the primary timeframe. If the stock cannot break down soon, the risk of a stop-out at $508 increases as the remaining horizon shrinks.
▼ Click to expandThe original short thesis for MSFT remains intact. The stock is trading just below a critical 4-hour resistance level ($500.05), with overbought conditions confirmed by a declining RSI (78.37) and weakening MACD histogram. The broader sector and rates environment continue to support the short case, and the first adverse barrier has not been breached. The stop at $508.00 remains intact, preserving the asymmetric risk/reward profile.
The original short thesis for MSFT remains intact. The stock is trading just below a critical 4-hour resistance level ($500.05), with overbought conditions confirmed by a declining RSI (78.37) and weakening MACD histogram. The broader sector and rates environment continue to support the short case, and the first adverse barrier has not been breached. The stop at $508.00 remains intact, preserving the asymmetric risk/reward profile.
▼ Click to expandWhile MSFT has shown relative strength in the short term, the technical structure is weakening. A break above $500.05 would invalidate the short thesis, and the stock could rally toward the stop at $508.00. Additionally, the broader market regime remains bullish, which could sustain upward pressure on MSFT if the resistance level fails to hold.
▼ Click to expandIntraday discovery triggered reanalysis on MSFT. Verdict: HOLD (0/3 EXIT). Conviction: 84.